Novozymes Total Long Term Liabilities 2011-2023 | NVZMY

Novozymes total long term liabilities for the quarter ending December 31, 2023 were $0.984B, a 2.33% increase year-over-year.

  • Novozymes total long term liabilities for 2023 were $0.984B, a 2.33% increase from 2022.
  • Novozymes total long term liabilities for 2022 were $0.962B, a 12.24% decline from 2021.
  • Novozymes total long term liabilities for 2021 were $1.096B, a 40.12% increase from 2020.

Novozymes Total Long Term Liabilities 2011-2023 | NVZMY

  • Novozymes total long term liabilities for 2023 were $0.984B, a 2.33% increase from 2022.
  • Novozymes total long term liabilities for 2022 were $0.962B, a 12.24% decline from 2021.
  • Novozymes total long term liabilities for 2021 were $1.096B, a 40.12% increase from 2020.
Related Stocks
Company NameMarket
Cap
Linde (LIN)$223B
Ecolab (ECL)$70.7B
Givaudan SA (GVDNY)$48.7B
PPG Industries (PPG)$29.7B
Celanese (CE)$13.8B
Axalta Coating Systems (AXTA)$7.9B
Element Solutions (ESI)$6.1B
Balchem (BCPC)$5.7B
CSW Industrials (CSWI)$5.5B
Valvoline (VVV)$5.3B
NewMarket (NEU)$5.3B
H B Fuller (FUL)$4.4B
Nissan Chemical (NNCHY)$4.4B
Ashland (ASH)$4.3B
Sensient Technologies (SXT)$3.2B
Quaker Houghton (KWR)$3B
Arcadium Lithium (ALTM)$2.7B
Hawkins (HWKN)$2.5B
Minerals Technologies (MTX)$2.3B
Orbia Advance, S.A.B De C.V (MXCHY)$2B
Perimeter Solutions, SA (PRM)$1.8B
Ingevity (NGVT)$1.4B
ELEMENTIS (ELMTY)$1.3B
DAQO New Energy (DQ)$1.1B
Mativ Holdings (MATV)$1B
Orion S.A (OEC)$986M
Huabao Holdings (HUIHY)$943M
Green Plains (GPRE)$868M
Westlake Chemical Partners LP (WLKP)$787M
AdvanSix (ASIX)$759M